TEV-56286

DRUG4 trials

Sponsors

Teva Branded Pharmaceutical Products R&D LLC, Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Healthy ParticipantsHealthy VolunteersMultiple System Atrophy

Phase 1

Mass Balance Clinical Trial With TEV-56286

CompletedNCT06627231

Teva Branded Pharmaceutical Products R&D, Inc.Healthy Participants

Start: 2024-10-08End: 2024-11-29Updated: 2026-08-07

A Trial to Assess TEV-56286 at Different Doses in Healthy Participants

RecruitingNCT07674940

Teva Branded Pharmaceutical Products R&D LLCHealthy Volunteers

Start: 2026-06-26End: 2027-01-22Target: 69Updated: 2026-09-08

Phase 2

A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

RecruitingNCT06568237

Teva Branded Pharmaceutical Products R&D LLCMultiple System Atrophy

Start: 2024-10-02End: 2027-09-15Target: 350Updated: 2026-07-20

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

RecruitingNCT07197866

Teva Branded Pharmaceutical Products R&D LLCMultiple System Atrophy

Start: 2025-09-30End: 2029-05-17Target: 200Updated: 2026-09-14